BI 764532
Boehringer Ingelheim
['sclc']
bi764532, bite of dll/cd3 in phase 1 trial of 2l sclc (and large cell nec and other nec) expressing dll with an orr 26% in sclc and seeing signs of durability.
hope for these difficult diseases!!
#asco23 
Medical Oncologist. Chief of Hem/Onc, PD of hem/onc fellowship, Dr Peter White Endowed Professor, & Associate Professor at The University of Toledo.